Stable lansoprazole formulation

Details for Australian Patent Application No. 2004287373 (hide)

Owner Dexcel, Ltd.

Inventors Avramoff, Avi; Azoulay, Valerie

Agent Cullen & Co

Pub. Number AU-A-2004287373

PCT Pub. Number WO2005/044240

Priority 60/515,672 31.10.03 US

Filing date 1 November 2004

Wipo publication date 19 May 2005

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/4439 (2006.01)

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044240 Priority application(s): WO2005/044240

6 July 2006 Change of Name(s) of Applicant(s), Section 104

  Dexcel, Ltd. The name of the applicant has been changed to Dexcel Ltd.

13 July 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 29 May 2006

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287375-Fluid dispensing components

2004287369-G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction